IT1261471B - Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego. - Google Patents

Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego.

Info

Publication number
IT1261471B
IT1261471B ITRM930286A ITRM930286A IT1261471B IT 1261471 B IT1261471 B IT 1261471B IT RM930286 A ITRM930286 A IT RM930286A IT RM930286 A ITRM930286 A IT RM930286A IT 1261471 B IT1261471 B IT 1261471B
Authority
IT
Italy
Prior art keywords
treatment
pharmaceutical composition
rectal administration
headache
preparation
Prior art date
Application number
ITRM930286A
Other languages
English (en)
Italian (it)
Inventor
Isabelle Richard
Isabelle Thielemans
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of ITRM930286A0 publication Critical patent/ITRM930286A0/it
Publication of ITRM930286A1 publication Critical patent/ITRM930286A1/it
Application granted granted Critical
Publication of IT1261471B publication Critical patent/IT1261471B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ITRM930286A 1992-05-07 1993-05-06 Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego. IT1261471B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (3)

Publication Number Publication Date
ITRM930286A0 ITRM930286A0 (it) 1993-05-06
ITRM930286A1 ITRM930286A1 (it) 1994-11-06
IT1261471B true IT1261471B (it) 1996-05-23

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930286A IT1261471B (it) 1992-05-07 1993-05-06 Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego.

Country Status (33)

Country Link
US (1) US5705506A (enExample)
EP (1) EP0639072B1 (enExample)
JP (1) JPH07506570A (enExample)
KR (1) KR100253111B1 (enExample)
AT (1) ATE163850T1 (enExample)
AU (1) AU670083B2 (enExample)
BE (1) BE1007024A5 (enExample)
BG (1) BG62120B1 (enExample)
BR (1) BR1100108A (enExample)
CA (1) CA2135179C (enExample)
CH (1) CH685920A5 (enExample)
CY (1) CY2039B1 (enExample)
CZ (1) CZ283512B6 (enExample)
DE (1) DE69317418T2 (enExample)
ES (1) ES2113533T3 (enExample)
FR (1) FR2690847B1 (enExample)
GB (2) GB9209882D0 (enExample)
GR (1) GR3026584T3 (enExample)
HK (1) HK95697A (enExample)
HU (2) HU227338B1 (enExample)
IE (1) IE75203B1 (enExample)
IL (1) IL105468A (enExample)
IT (1) IT1261471B (enExample)
NO (1) NO306700B1 (enExample)
NZ (1) NZ252132A (enExample)
OA (1) OA10109A (enExample)
RO (1) RO112993B1 (enExample)
RU (1) RU2118527C1 (enExample)
SG (1) SG46649A1 (enExample)
TW (1) TW231970B (enExample)
UA (1) UA37206C2 (enExample)
WO (1) WO1993021916A1 (enExample)
ZA (1) ZA933178B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
PT1421939E (pt) * 1998-03-26 2010-07-12 Astellas Pharma Inc Preparaã†o da libertaã†o sustentada de um composto de macrëlido como tracolimus
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
CA2905541C (en) 2008-01-09 2020-02-11 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
AU2011316225B2 (en) 2010-10-15 2016-05-19 Contera Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
BR112014025907B1 (pt) 2012-04-18 2023-02-14 Contera Pharma Aps Formulação farmacêutica disponível para administração por via oral adequada para manejo aprimorado de transtornos do movimento
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
AU2017297718B2 (en) 2016-07-11 2023-06-08 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
FR2488606A1 (fr) * 1980-08-12 1982-02-19 Glaxo Group Ltd Derives indoliques, leur preparation et leurs applications en tant que medicaments
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GR79215B (enExample) * 1982-06-07 1984-10-22 Glaxo Group Ltd
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
DE3542698A1 (de) * 1984-12-04 1986-06-05 Glaxo Group Ltd., London Indolderivate, verfahren zu ihrer herstellung und sie enthaltende, pharmazeutische zubereitungen
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
IL87437A0 (en) * 1987-08-13 1989-01-31 Glaxo Group Ltd Indole derivatives,their preparation and pharmaceutical compositions containing them
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
IL105468A0 (en) 1993-08-18
GB9309209D0 (en) 1993-06-16
SG46649A1 (en) 1998-02-20
CZ272394A3 (en) 1995-10-18
CA2135179C (en) 2000-12-05
RU2118527C1 (ru) 1998-09-10
HU211638A9 (en) 1995-12-28
DE69317418D1 (de) 1998-04-16
ITRM930286A1 (it) 1994-11-06
CY2039B1 (en) 1998-04-30
GB2266665A (en) 1993-11-10
ATE163850T1 (de) 1998-03-15
ITRM930286A0 (it) 1993-05-06
CA2135179A1 (en) 1993-11-11
FR2690847A1 (fr) 1993-11-12
JPH07506570A (ja) 1995-07-20
NO306700B1 (no) 1999-12-13
UA37206C2 (uk) 2001-05-15
HUT71418A (en) 1995-11-28
NZ252132A (en) 1996-09-25
ES2113533T3 (es) 1998-05-01
HK95697A (en) 1997-08-08
HU227338B1 (en) 2011-04-28
RO112993B1 (ro) 1998-03-30
IL105468A (en) 1998-09-24
CH685920A5 (fr) 1995-11-15
NO944214D0 (no) 1994-11-04
BR1100108A (pt) 1999-12-07
KR100253111B1 (en) 2000-07-01
GB2266665B (en) 1996-05-22
NO944214L (no) 1994-11-07
TW231970B (enExample) 1994-10-11
EP0639072A1 (en) 1995-02-22
IE930339A1 (en) 1993-11-17
AU4064093A (en) 1993-11-29
CZ283512B6 (cs) 1998-04-15
DE69317418T2 (de) 1998-07-30
GB9209882D0 (en) 1992-06-24
EP0639072B1 (en) 1998-03-11
IE75203B1 (en) 1997-08-27
OA10109A (en) 1996-12-18
BE1007024A5 (fr) 1995-02-21
WO1993021916A1 (en) 1993-11-11
BG99167A (bg) 1995-06-30
FR2690847B1 (fr) 1995-06-09
AU670083B2 (en) 1996-07-04
GR3026584T3 (en) 1998-07-31
US5705506A (en) 1998-01-06
ZA933178B (en) 1994-01-10
BG62120B1 (bg) 1999-03-31

Similar Documents

Publication Publication Date Title
IT1282352B1 (it) Composizione farmaceutica, in particolare essiccata mediante congelamento, per somministrazione orale di ondansetron e metodo per
CY1105931T1 (el) Χρηση ενος αγωνιστη/ανταγωνιστη οιστρογονου για την αντιμετωπιση γυναικειας σεξουαλικης δυσλειτουργιας
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
IT1261471B (it) Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego.
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
BR9808429A (pt) Composição farmacêutica e processo para a sua preparação.
SV1998000029A (es) Compuestos de pirazina ref. pg3186
RU95106649A (ru) Производные бензимидазола в качестве непептидильных антагонистов рецепторов тахикинина, способ получения, фармацевтическая композиция
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
FI973518A7 (fi) Piperidinoalkanoliyhdistettä tai sen farmaseuttisesti hyväksyttävää suolaa sisltävä farmaseuttinen koostumus kiinteässä yksikköannosmuodossa
SE9504661D0 (sv) New compounds
AR002355A1 (es) Composiciones y metodos para administracion local de agentes farmaceuticamente activos.
SE0102036D0 (sv) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
EA200301223A1 (ru) Лекарственные формы окскарбазепина
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
DK1057828T3 (da) Orale trovafloxacin-suspensioner
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
ATE319715T1 (de) Antikonvulsive pseudofructopyranose sulfamate
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
EA199901116A1 (ru) Композиция, включающая 5-[4-[2-(n-метил-n-2-пиридил)-амино)этокси]бензил]тиазолидин-2,4-дион
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530